Vertex Pharmaceuticals Inc. buy Subdi
Start price
26.01.18
/
50%
€150.98
Target price
06.02.18
€178.60
Performance (%)
-8.89%
End price
06.02.18
€137.56
Summary
This prediction ended on 06.02.18 with a price of €137.56. With a performance of -8.89%, the BUY prediction for Vertex Pharmaceuticals Inc. by Subdi closed slightly in the red. Subdi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.461% | 0.461% | -11.573% | 32.679% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by Subdi for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 26.01.2018 der Buy-Einschätzung von tamam mit dem Kursziel 170$ zu.
Überschrift: tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
(Vom Mitglied beendet)